Department of Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama 359-8513, Japan.
J Clin Oncol. 2011 Jun 20;29(18):2550-6. doi: 10.1200/JCO.2010.33.7725. Epub 2011 May 16.
To clarify the prognostic impact of tumor nodules without residual lymph node (LN) structure (ND) in colorectal cancer and to determine optimal categorization of ND in tumor staging.
A multicenter, retrospective pathologic review was performed for 1716 patients with stages I to III curatively resected colorectal cancer treated at 11 institutions between 1994 and 1998. An additional 2242 patients from nine institutions were enrolled between 1999 and 2003 as a second cohort to validate the results.
LN metastasis (LNM) and ND were observed in 33.7% and 16.0% (smooth-contour nodule [S-ND], 8.2%; irregular-contour nodule [I-ND], 10.7%) of patients in the first cohort. S-ND and I-ND were similarly distributed in the regional area. There was no considerable difference in the impact on survival between S-ND (hazard ratio [HR], 2.7; 95% CI, 1.9 to 3.8) and I-ND (HR, 4.3; 95% CI, 3.3 to 5.8) or between LNM (HR, 4.5; 95% CI, 3.4 to 6.0) and ND (HR, 4.0; 95% CI, 3.1 to 5.3). LNM and ND were similarly associated with the mode of recurrence. Tumor nodules ≥ 5 mm growing with venous/perineural invasion (ND [v/pni+]), judged with 0.61 κ value among 11 observers, had an independent prognostic value for 5-year survival of 42%; similar results were observed in the second cohort.
These results do not support the TNM system in which S-ND is treated differently from I-ND in tumor staging; LNM and ND should be considered together in the same category. The presence of ND (v/pni+) has a considerable adverse prognostic effect.
阐明结直肠癌中无残留淋巴结(LN)结构的肿瘤结节(ND)的预后影响,并确定肿瘤分期中 ND 的最佳分类。
对 1994 年至 1998 年期间在 11 家机构接受根治性切除的 I 期至 III 期结直肠癌患者进行了一项多中心回顾性病理检查,共有 1716 例患者入组。在 1999 年至 2003 年期间,从 9 家机构纳入了另外 2242 例患者作为第二个队列,以验证结果。
在第一队列中,33.7%(有 LN 转移[LNM])和 16.0%(有 ND)的患者存在 LNM 和 ND(平滑轮廓结节[S-ND],8.2%;不规则轮廓结节[I-ND],10.7%)。S-ND 和 I-ND 在区域分布上相似。S-ND(危险比[HR],2.7;95%置信区间[CI],1.9 至 3.8)和 I-ND(HR,4.3;95% CI,3.3 至 5.8)之间,或 LNM(HR,4.5;95% CI,3.4 至 6.0)和 ND(HR,4.0;95% CI,3.1 至 5.3)之间,对生存的影响无显著差异。LNM 和 ND 与复发模式同样相关。肿瘤结节≥5mm 且伴有静脉/神经周围侵犯(ND[v/pni+]),在 11 位观察者中具有 0.61 κ 值,具有独立的 5 年生存率预测价值,为 42%;第二个队列也观察到了类似的结果。
这些结果不支持 TNM 系统,该系统将 S-ND 与 I-ND 在肿瘤分期中进行不同的处理;应将 LNM 和 ND 视为同一类别。ND(v/pni+)的存在具有显著的不良预后影响。